Lobeglitazone-d4
Product Specifications
UNSPSC Description
Lobeglitazone-d4 is deuterium labeled Lobeglitazone. Lobeglitazone is a new type of thiazolidinedione. Lobeglitazone can be used to prevent type 2 diabetes mellitus (T2DM)[1][2].
Target Antigen
Isotope-Labeled Compounds; Others
Type
Isotope-Labeled Compounds
Related Pathways
Others
Field of Research
Metabolic Disease
Smiles
O=C(N1)SC(CC2=CC=C(OC([2H])([2H])C([2H])([2H])N(C3=NC=NC(OC4=CC=C(OC)C=C4)=C3)C)C=C2)C1=O
Molecular Weight
484.56
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.|[2]Bae J, et al. Lobeglitazone: A Novel Thiazolidinedione for the Management of Type 2 Diabetes Mellitus. Diabetes Metab J. 2021 May;45(3):326-336.
Shipping Conditions
Room temperature
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
43130141 1x10<sup>6</sup> cells/1.0ml
SCAX2 CRISPR Knock Out 293T Cell Line (Human)
Ask
View Details 